cdp ethanolamine has been researched along with Insulin Resistance in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruce, CR; Burch, ML; Febbraio, MA; Frank, M; Genders, AJ; Jackowski, S; Kowalski, GM; Lamon, S; Lee-Young, RS; McGee, SL; Meikle, PJ; Risis, S; Russell, AP; Selathurai, A; Sepulveda, P; Watt, MJ | 1 |
| Bakovic, M; Bonen, A; Fullerton, MD; Hakimuddin, F | 1 |
2 other study(ies) available for cdp ethanolamine and Insulin Resistance
| Article | Year |
|---|---|
The CDP-Ethanolamine Pathway Regulates Skeletal Muscle Diacylglycerol Content and Mitochondrial Biogenesis without Altering Insulin Sensitivity.
Topics: Animals; Cytidine Diphosphate; Diglycerides; Ethanolamines; Glucose; Insulin Resistance; Lipid Metabolism; Mice; Mice, Knockout; Muscle, Skeletal; Obesity; Organelle Biogenesis; RNA Nucleotidyltransferases | 2015 |
The development of a metabolic disease phenotype in CTP:phosphoethanolamine cytidylyltransferase-deficient mice.
Topics: Animals; Cytidine Diphosphate; Diglycerides; Ethanolamines; Fatty Liver; Female; Gene Expression Regulation; Hypertriglyceridemia; Insulin Resistance; Lipid Metabolism, Inborn Errors; Male; Metabolic Syndrome; Mice; Mice, Knockout; Phosphatidylethanolamines; Phosphatidylserines; RNA Nucleotidyltransferases; Triglycerides | 2009 |